Cargando…

Non-Alcoholic Fatty Liver Disease, a Marker of Subclinical Atherosclerosis Applicable Only to Metabolic Syndrome?: Time to Organize the Connection between Metabolism and Atherosclerosis

Detalles Bibliográficos
Autor principal:	Lee, Seung-Pyo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Echocardiography 2012
Materias:	Editorial Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3498308/ https://www.ncbi.nlm.nih.gov/pubmed/23185654 http://dx.doi.org/10.4250/jcu.2012.20.3.124

Ejemplares similares

Epicardial fat: a novel marker of subclinical atherosclerosis in clinical practice?
por: Katsiki, Niki, et al.
Publicado: (2017)

Association of non-alcoholic fatty liver disease with cardiovascular disease and subclinical atherosclerosis
por: Sao, Rahul, et al.
Publicado: (2017)

Metabolic dysfunction-associated fatty liver disease increased the risk of subclinical carotid atherosclerosis in China
por: Lei, Fang, et al.
Publicado: (2023)

Subclinical atherosclerosis: A hidden threat for patients with ankylosing spondylitis
por: Hamdi, Wafa, et al.
Publicado: (2019)

A significant risk of metabolic dysfunction-associated fatty liver disease plus diabetes on subclinical atherosclerosis
por: Bessho, Rieko, et al.
Publicado: (2022)

Insulin metabolism markers are predictors of subclinical atherosclerosis among overweight and obese children and adolescents
por: Asghari, Golaleh, et al.
Publicado: (2018)

Association of Endothelial and Oxidative Stress with Metabolic Syndrome and Subclinical Atherosclerosis: Multi-Ethnic Study of Atherosclerosis
por: Vaidya, Dhananjay, et al.
Publicado: (2011)

Metabolic dysfunction-associated fatty liver disease reflects a significantly higher risk of hypertension than non-alcoholic fatty liver disease
por: Uehara, Tatsuki, et al.
Publicado: (2023)

Risk of subclinical atherosclerosis across metabolic transition in individuals with or without fatty liver disease: a prospective cohort study
por: Xin, Zhuojun, et al.
Publicado: (2023)

Uncovering the Cardiovascular Threat: A Comprehensive Examination of Liver Fibrosis and Subclinical Atherosclerosis in Non-alcoholic Fatty Liver Disease
por: Sharma, Niketa, et al.
Publicado: (2023)

Diabetes and Subclinical Coronary Atherosclerosis
por: Lee, Chang Hoon, et al.
Publicado: (2018)

Association between Metabolic Components and Subclinical Atherosclerosis in Korean Adults
por: Hwang, In Cheol, et al.
Publicado: (2012)

Fatty Liver Increases the Association of Metabolic Syndrome With Diabetes and Atherosclerosis
por: Juárez-Rojas, Juan G., et al.
Publicado: (2013)

AIMing 2 treat atherosclerosis
por: Soehnlein, Oliver, et al.
Publicado: (2022)

A role for lipophagy in atherosclerosis
por: Laval, Thomas, et al.
Publicado: (2023)

Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
por: Fadaei, Reza, et al.
Publicado: (2018)

Association of anti-oxidative capacity of HDL with subclinical atherosclerosis in subjects with and without non-alcoholic fatty liver disease
por: Karami, Sara, et al.
Publicado: (2021)

Severe, but not mild to moderate, non-alcoholic fatty liver disease associated with increased risk of subclinical coronary atherosclerosis
por: Hsiao, Chia-Chi, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease Is Associated with the Presence and Morphology of Subclinical Coronary Atherosclerosis
por: Kang, Min Kyoung, et al.
Publicado: (2015)

Nonalcoholic Fatty Liver Disease in Hispanic Youth With Dysglycemia: Risk for Subclinical Atherosclerosis?
por: Bacha, Fida, et al.
Publicado: (2017)

Association and Prediction of Subclinical Atherosclerosis by Nonalcoholic Fatty Liver Disease in Asymptomatic Patients
por: Bae, Ye Seul, et al.
Publicado: (2020)

Metabolic health phenotype better predicts subclinical atherosclerosis than body mass index-based obesity phenotype in the non-alcoholic fatty liver disease population
por: Wang, Yaqin, et al.
Publicado: (2023)

Role of Surrogate Markers of Atherosclerosis in Clinical and Subclinical Thyroidism
por: Gunduz, Mehmet, et al.
Publicado: (2012)

Chemerin is not associated with subclinical atherosclerosis markers in prediabetes and diabetes
por: Aydın, Kadriye, et al.
Publicado: (2016)

Roles of the Metabolic Syndrome, HDL Cholesterol, and Coronary Atherosclerosis in Subclinical Inflammation
por: Rein, Philipp, et al.
Publicado: (2010)

Differential impact of metabolic syndrome on subclinical atherosclerosis according to the presence of diabetes
por: Won, Ki-Bum, et al.
Publicado: (2013)

Impact of Subclinical Atherosclerosis on Cardiovascular Disease Events in Individuals With Metabolic Syndrome and Diabetes: The Multi-Ethnic Study of Atherosclerosis
por: Malik, Shaista, et al.
Publicado: (2011)

Circulating levels of FAM19A5 are inversely associated with subclinical atherosclerosis in non-alcoholic fatty liver disease
por: Yari, Fatemeh Ali, et al.
Publicado: (2021)

Association between non-alcoholic fatty liver disease and subclinical atherosclerosis in Western and Asian cohorts: an updated meta-analysis
por: Wong, Mark Yu Zheng, et al.
Publicado: (2021)

Is subclinical atherosclerosis associated with visceral fat and fatty liver in adolescents with type 1 diabetes?
por: Atwa, Hoda, et al.
Publicado: (2018)

Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease
por: Arai, Taeang, et al.
Publicado: (2019)

Atherosclerosis at your fingertips?
por: Swenne, C.A.
Publicado: (2015)

Normal-weight obesity is associated with increased risk of subclinical atherosclerosis
por: Kim, Sohee, et al.
Publicado: (2015)

Subclinical atherosclerosis in patients with psoriasis
por: Balta, Ilknur, et al.
Publicado: (2015)

Predictors of subclinical atherosclerosis in HIV
por: Fernández Soto, Julia, et al.
Publicado: (2023)

Metabolic syndrome criteria as predictors of subclinical atherosclerosis based on the coronary calcium score
por: Seo, Mi Hae, et al.
Publicado: (2015)

Influence of Metabolic Syndrome on Small, Dense LDL, and Subclinical Atherosclerosis in Older Subjects
por: Yoshino, Hiroshi, et al.
Publicado: (2023)

Cardiac Insulin Resistance in Subjects With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis
por: Devesa, Ana, et al.
Publicado: (2023)

Circulating Tryptase as a Marker for Subclinical Atherosclerosis in Obese Subjects
por: Moreno, María, et al.
Publicado: (2014)

Nonalcoholic fatty liver disease contributes to subclinical atherosclerosis: A systematic review and meta‐analysis
por: Zhou, Yao‐Yao, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_d3202eo2c1lbm9acvjnao0lns9